Label-Free Quantitative Proteomic Screening of Candidate Plasma Biomarkers for the Prognosis of Breast Cancer with Different Lymph Node Statuses.

CONCLUSIONS AND CLINICAL RELEVANCE: The present dataset provides a list of candidate biomarkers that could be used for early differentiation diagnosis and prognosis of breast cancer with lymph node metastasis. This article is protected by copyright. All rights reserved.
PMID: 29384592 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - January 31, 2018 Category: Cancer & Oncology Authors: Chen L, Zhao W, He J, Li L, Meng D, Cai D, Yu J, Chen D, Wu Y, Zhou T Tags: Proteomics Clin Appl Source Type: research